NCT00295139 Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients Status COMPLETED Phase NA
NCT00294008 A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR) Status COMPLETED Phase N/A
NCT00290121 Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics Status COMPLETED Phase PHASE4
NCT00288366 Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome Status COMPLETED Phase NA
NCT00288353 Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes Status TERMINATED Phase PHASE3
NCT00288340 Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging Status COMPLETED Phase NA
NCT00287820 Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism Status COMPLETED Phase PHASE4
NCT00287352 Study of Amantadine for Weight Stabilization During Olanzapine Treatment Status COMPLETED Phase PHASE1
NCT00286299 Treatment Effects From Aerobic Endurance Training and Maximal Strength Training in Patients Suffering From Schizophrenia Status COMPLETED Phase NA
NCT00283517 A Registry of Treatment Adherence for Patients With Schizophrenia Status COMPLETED Phase N/A
NCT00283179 Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00272168 The Use of Skills Training to Augment Compensated Work Therapy (CWT)/VI for Veterans With SMI Status COMPLETED Phase NA
NCT00269919 An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophrenia Status COMPLETED Phase PHASE4
NCT00269464 Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype? Status COMPLETED Phase N/A